132 related articles for article (PubMed ID: 7516166)
1. Synthesis and muscarinic receptors affinity of a series of antagonist bivalent ligands.
Piergentili A; Quaglia W; Tayebati SK; Paparelli F; Malmusi L; Brasili L
Farmaco; 1994 Feb; 49(2):83-7. PubMed ID: 7516166
[TBL] [Abstract][Full Text] [Related]
2. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion.
Noronha-Blob L; Prosser JC; Sturm BL; Lowe VC; Enna SJ
Eur J Pharmacol; 1991 Aug; 201(2-3):135-42. PubMed ID: 1724648
[TBL] [Abstract][Full Text] [Related]
3. Stereoselectivity at muscarinic receptor subtypes: observations with the enantiomers of phenglutarimide.
Lambrecht G; Feifel R; Mutschler E
Chirality; 1989; 1(2):170-3. PubMed ID: 2642045
[TBL] [Abstract][Full Text] [Related]
4. Assessment of selectivity of muscarinic antagonists for M1 and M2 receptors in rabbit isolated vas deferens.
Eltze M
Pharmacology; 1988; 37 Suppl 1():40-7. PubMed ID: 2467317
[TBL] [Abstract][Full Text] [Related]
5. Distinct functional muscarinic receptors in guinea-pig gallbladder, ileum and atria.
Karaalp A; Akici A; Akbulut H; Ulusoy NB; Oktay S
Pharmacol Res; 1999 May; 39(5):389-95. PubMed ID: 10328997
[TBL] [Abstract][Full Text] [Related]
6. Bicyclic dioxolanes as potential antimuscarinic agents.
Piergentili A; Angeli P; Giannella M; Pigini M; Quaglia W; Tayebati SK
Arzneimittelforschung; 1996 Feb; 46(2):99-105. PubMed ID: 8720297
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characteristics of indoline derivatives in muscarinic receptor subtypes.
Adachi S; Koike K; Takayanagi I
Pharmacology; 1996 Oct; 53(4):250-8. PubMed ID: 8958564
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship studies in a series of 2-substituted 1,3-dioxolanes modified at the cationic head.
Angeli P; Brasili L; Cingolani ML; Marucci G; Piergentili A; Pigini M; Quaglia W
Bioorg Med Chem; 1997 Apr; 5(4):731-7. PubMed ID: 9158872
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines.
Budriesi R; Cacciaguerra S; Toro RD; Bolognesi ML; Chiarini A; Minarini A; Rosini M; Spampinato S; Tumiatti V; Melchiorre C
Br J Pharmacol; 2001 Mar; 132(5):1009-16. PubMed ID: 11226131
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic properties of compounds related to arecaidine propargyl ester.
Tumiatti V; Wehrle J; Hildebrandt C; Moser U; Dannhardt G; Mutschler E; Lambrecht G
Arzneimittelforschung; 2000 Jan; 50(1):11-5. PubMed ID: 10683710
[TBL] [Abstract][Full Text] [Related]
12. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
Shannon HE; Bymaster FP; Calligaro DO; Greenwood B; Mitch CH; Sawyer BD; Ward JS; Wong DT; Olesen PH; Sheardown MJ; Swedberg MD; Suzdak PD; Sauerberg P
J Pharmacol Exp Ther; 1994 Apr; 269(1):271-81. PubMed ID: 7909557
[TBL] [Abstract][Full Text] [Related]
13. Aliphatic and heterocyclic analogues of arecaidine propargyl ester. Structure-activity relationships of mono- and bivalent ligands at muscarinic M1 (M4), M2 and M3 receptor subtypes.
Moser U; Gubitz C; Galvan M; Immel-Sehr A; Lambrecht G; Mutshcler E
Arzneimittelforschung; 1995 Apr; 45(4):449-55. PubMed ID: 7779140
[TBL] [Abstract][Full Text] [Related]
14. Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus.
Dörje F; Friebe T; Tacke R; Mutschler E; Lambrecht G
Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):284-9. PubMed ID: 2280796
[TBL] [Abstract][Full Text] [Related]
15. Functional determination of McN-A-343 affinity for M1 muscarinic receptors.
Micheletti R; Schiavone A
J Pharmacol Exp Ther; 1990 Apr; 253(1):310-4. PubMed ID: 1691785
[TBL] [Abstract][Full Text] [Related]
16. Glycopyrronium bromide blocks differentially responses mediated by muscarinic receptor subtypes.
Fuder H; Meincke M
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):591-5. PubMed ID: 7689704
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine.
Piergentili A; Gentili F; Ghelfi F; Marucci G; Pigini M; Quaglia W; Giannella M
Bioorg Med Chem; 2003 Sep; 11(18):3901-11. PubMed ID: 12927850
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.
Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Martini E; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
J Med Chem; 2007 Mar; 50(6):1409-13. PubMed ID: 17305327
[TBL] [Abstract][Full Text] [Related]
19. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C
J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650
[TBL] [Abstract][Full Text] [Related]
20. New analogues of oxotremorine and oxotremorine-M: estimation of their in vitro affinity and efficacy at muscarinic receptor subtypes.
Barocelli E; Ballabeni V; Bertoni S; Dallanoce C; De Amici M; De Micheli C; Impicciatore M
Life Sci; 2000 Jun; 67(6):717-23. PubMed ID: 12659177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
